Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dopamine receptor D1 (DRD1) is a G protein-coupled receptor and a member of the dopamine receptor family. It is the most abundant dopamine receptor in the central nervous system and plays key roles in reward processing, motor control, and cognitive functions. DRD1 primarily couples to Gαs/olf, leading to stimulation of adenylyl cyclase and increased cAMP levels. Dysfunctional DRD1 signaling has been implicated in neuropsychiatric disorders such as Parkinson’s disease, schizophrenia, and ADHD. Current pharmacotherapies targeting this pathway focus on PD and cognitive impairment but also play roles indirectly via drugs like L-DOPA.
Activation of adenylyl cyclase leading to increased intracellular cAMP levels
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dopamine Receptor D1 Subtype (DRD1).